Stock data
Connect Biopharma Holdings Limited (CNTB)
Connect Biopharma Holdings Limited (CNTB) reported revenue of US$0.06M and net income of -US$55.48M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.06M | — | -US$58.07M | -US$55.48M | — |
| 2024 | US$26.03M | — | -US$22.45M | -US$15.63M | — |
| 2023 | US$0.00M | — | -US$69.06M | -US$62.11M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$2.77M | -US$17.28M | — |
| 2026-03-31 | US$0.17M | -US$19.40M | — |
| 2025-12-31 | US$0.00M | -US$15.11M | — |
| 2025-09-30 | US$0.02M | -US$17.20M | — |
| 2025-06-30 | US$0.05M | -US$12.90M | — |
| 2025-03-31 | US$0.00M | -US$10.27M | — |
| 2024-12-31 | — | -US$8.91M | — |
| 2024-09-30 | US$1.22M | -US$12.88M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.